HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q4 2021

SEC EDGAR SourceSEC Filings

Top Holdings76 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ONCONC
ADR

BEIGENE LTD-ADR

5.5M$1.5B22.9%$134.02+104.00%
13 qtrssince 2018-Q4
Unchanged
0

ON HLDG AG

16M$604M9.3%$30.90+23.20%
2 qtrssince 2021-Q3
Unchanged
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

11.8M$550.2M8.5%$47.04+5.81%
7 qtrssince 2020-Q2
Increased
65

SALESFORCE.COM INC

1.9M$490.4M7.6%$213.56+18.12%
8 qtrssince 2020-Q1
Increased
86
NBPNBP
ADR

NOVABRIDGE BIOSCIENCES

7.2M$340.4M5.3%$47.24+1.37%
6 qtrssince 2020-Q3
Unchanged
0
JDJD
ADR

JD.COM INC-ADR

4.8M$334M5.2%$49.36+29.41%
13 qtrssince 2018-Q4
Unchanged
0
SESE
ADR

SEA LTD-ADR

1.2M$276.9M4.3%$247.63-9.42%
2 qtrssince 2021-Q3
Increased
91

DOORDASH INC - A

1.3M$193M3.0%$142.75+6.75%
5 qtrssince 2020-Q4
Increased
57
IQIQ
ADR

IQIYI INC

38.6M$176.2M2.7%$18.39-74.44%
13 qtrssince 2018-Q4
Unchanged
0
LILI
ADR

LI AUTO INC

5M$160.7M2.5%$30.61+4.38%
2 qtrssince 2021-Q3
Increased
84

CYTEK BIOSCIENCES INC

8.8M$142.9M2.2%$20.96-20.66%
2 qtrssince 2021-Q3
Unchanged
0

MONDELEZ INTERNATIONAL INC-A

1.9M$123.5M1.9%$33.70+75.79%
13 qtrssince 2018-Q4
Unchanged
0
ENFNENFNDelisted

ENFUSION INC

5M$104.2M1.6%
1 qtr
New
68
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

5M$100.8M1.6%$62.02-69.22%
6 qtrssince 2020-Q3
Unchanged
0

BRIDGEBIO PHARMA INC

5.4M$89.4M1.4%$28.25-48.50%
11 qtrssince 2019-Q2
Unchanged
0
YSYSG
ADR

Yatsen Holding Limited

40.5M$87M1.3%

GOSSAMER BIO INC

7.4M$83.9M1.3%$16.82-32.95%
12 qtrssince 2019-Q1
Unchanged
0
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

9M$75.3M1.2%$19.34-59.05%
4 qtrssince 2021-Q1
Unchanged
0

Erasca, Inc.

4.7M$73.6M1.1%$19.84-7.86%
2 qtrssince 2021-Q3
Unchanged
0

COUPANG INC

2.4M$71.3M1.1%$28.37+4.28%
2 qtrssince 2021-Q3
Increased
52
$6.5B
AUM
76
Positions
Q4 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
+21%Q3'20$13.2B-5%Q4'20$12.6B-20%Q1'21$10.1B-4%Q2'21$9.7B-21%Q3'21$7.6B-15%Q4'21$6.5B
Activity profile
$ moved · Q4'21
New10%Increased41%Decreased21%Exited27%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q3%1-4Q33%1-2Y28%2Y+37%

HHLR ADVISORS, LTD. manages $6.5B across 76 positions as of Q4 2021. Top holdings: ONC (22.9%), ONON (9.3%), LEGN (8.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q4 2021 Summary

Active quarter - 3 new positions, 12 exits, 8 increased. Top move: SE (INCREASED, conviction 91). Portfolio: $6.5B across 76 positions.

Top holdings by portfolio weight

Total AUM$6B
ONC22.91%
ONON9.33%
LEGN8.50%
CRM7.58%
NBP5.26%
JD5.16%
SE4.28%
DASH2.98%
IQ2.72%
LI2.48%
Other2.21%

Portfolio allocation by GICS sector

Sectors9
Healthcare47.47%
Consumer Cyclical29.83%
Technology9.91%
Communication Services4.11%
Consumer Defensive3.31%
Unknown2.69%
Real Estate1.56%
Financial Services1.02%
Industrials0.11%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used